https://www.selleckchem.com/pr....oducts/abbv-2222.htm
Patients testing positive for SARS-CoV-2 had significantly more symptoms (4.4 vs 0.3, p less then 0.001) than patients testing negative. Among patients who were antibody-positive, quantitative titers indicated moderate to high antibody response. In GD adults, male gender, older age, increased BMI, comorbidities, GBA genotype, prior splenectomy and treatment status were not associated with the probability of reporting symptoms or testing positive. No patient required COVID-19-specific treatments and there were no deaths. Our data sugge
Beğen
Yorum Yap
Paylaş
